Garvan Institute of Medical Research
Antony Cooper is a cell and molecular biologist / geneticist with strong interests in elucidating how cellular dysfunction results in human diseases, with a specific interest in neurodegenerative disease such as Parkinson’s Disease. His research on neurodegenerative diseases focuses on understanding the basis of Parkinson’s Disease.
Antony completed a PhD at McGill University working on membrane trafficking, and post-doctoral studies at the University of Oregon involving both protein splicing and proteostasis/protein quality control in the endoplasmic reticulum (ER). As an Assistant Professor at the University of Missouri his interests evolved to protein misfolding, ER stress and oxidative stress, factors common to many neurodegenerative diseases. As a tenured Associate Professor in Missouri and since returning to Australia at the Garvan Institute he has focused his research on Parkinson’s disease.
This person is not in any teams
Garvan Institute of Medical Research
4 followers
The Garvan Institute of Medical Research has made significant breakthroughs in the understanding and treatment of disease. We are leaders in genomic and personalised medicine, use cutting-edge technology to study, prevent and treat major diseases like cancer, osteoporosis, diabetes, obesity, immonological, skeletal and neurological disease.